CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $399,000 | -67.7% | 68,516 | -66.9% | 0.03% | -69.3% |
| Q2 2022 | $1,236,000 | +222.7% | 206,954 | +152.6% | 0.10% | +215.6% |
| Q1 2022 | $383,000 | +175.5% | 81,941 | +47.5% | 0.03% | +52.4% |
| Q2 2021 | $139,000 | -21.0% | 55,555 | -8.2% | 0.02% | -46.2% |
| Q1 2021 | $176,000 | +402.9% | 60,548 | +456.4% | 0.04% | +254.5% |
| Q4 2020 | $35,000 | – | 10,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |